Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.24B |
| 2 |
Microsoft
MSFT
|
+$1.09B |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$497M |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$462M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.14B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$834M |
| 3 |
DuPont de Nemours
DD
|
+$438M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$367M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$323M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.52% |
| 2 | Financials | 7.65% |
| 3 | Consumer Discretionary | 5.72% |
| 4 | Communication Services | 5.59% |
| 5 | Healthcare | 5.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2801
United Fire Group
UFCS
$1.32B
| $919K | ﹤0.01% |
26,404
-15,254
| -37% | -$481K |
|
|
CIR
2802
DELISTED
CIRCOR International, Inc
CIR
| $918K | ﹤0.01% |
26,337
+4,190
| +19% | +$151K |
|
2803
Invesco Solar ETF
TAN
$1.39B
| $916K | ﹤0.01% |
9,984
-14,430
| -59% | -$1.52M |
|
2804
Milestone Pharmaceuticals
MIST
$138M
| $909K | ﹤0.01% |
156,876
+119,561
| +320% | +$875K |
|
|
KBAL
2805
DELISTED
Kimball International
KBAL
| $909K | ﹤0.01% |
64,917
+885
| +1% | +$11.5K |
|
2806
RE/MAX Holdings
RMAX
$193M
| $905K | ﹤0.01% |
22,980
-1,980
| -8% | -$77.6K |
|
2807
SunCoke Energy
SXC
$720M
| $901K | ﹤0.01% |
128,412
+8,618
| +7% | +$53.2K |
|
2808
Axogen
AXGN
$2.27B
| $900K | ﹤0.01% |
44,405
+10,611
| +31% | +$210K |
|
|
VISN
2809
Vistance Networks Inc
VISN
$2.65B
| $900K | ﹤0.01% |
58,611
+43,429
| +286% | +$651K |
|
|
SWCH
2810
DELISTED
Switch, Inc. Class A Common Stock
SWCH
| $898K | ﹤0.01% |
55,191
+49,869
| +937% | +$831K |
|
2811
ARK Genomic Revolution ETF
ARKG
$1.55B
| $896K | ﹤0.01% |
10,091
+1,560
| +18% | +$155K |
|
2812
Vanguard Information Technology ETF
VGT
$139B
| $896K | ﹤0.01% |
20,000
| – | – |
|
2813
CAE Inc. Common Shares
CAE
$8.3B
| $893K | ﹤0.01% |
31,362
+29,136
| +1,309% | +$775K |
|
2814
American Vanguard Corp
AVD
$68.4M
| $892K | ﹤0.01% |
43,699
+4,115
| +10% | +$78.4K |
|
|
SNP
2815
DELISTED
CHINA PETROLEUM & CHEMICAL CORPORATION ADS (REP 100 ORDINARY H SHARES)
SNP
| $892K | ﹤0.01% |
16,908
+6,823
| +68% | +$356K |
|
2816
Midland States Bancorp
MSBI
$699M
| $891K | ﹤0.01% |
32,093
+25,178
| +364% | +$585K |
|
2817
PUT
Fastenal
FAST
$54.7B
| $890K | ﹤0.01% |
35,400
-19,600
| -36% | -$469K |
|
|
HTBK
2818
DELISTED
Heritage Commerce
HTBK
| $889K | ﹤0.01% |
72,767
+25,973
| +56% | +$260K |
|
|
FLY
2819
DELISTED
Fly Leasing Limited
FLY
| $884K | ﹤0.01% |
52,474
+8,374
| +19% | +$94.6K |
|
2820
Genesco
GCO
$425M
| $883K | ﹤0.01% |
18,581
-7,923
| -30% | -$341K |
|
2821
Myers Industries
MYE
$1.29B
| $883K | ﹤0.01% |
44,707
+5,001
| +13% | +$107K |
|
2822
IMAX
IMAX
$2.62B
| $882K | ﹤0.01% |
43,868
+27,893
| +175% | +$556K |
|
2823
Alphatec Holdings
ATEC
$1.46B
| $878K | ﹤0.01% |
55,582
+37,806
| +213% | +$595K |
|
2824
Core Laboratories
CLB
$488M
| $878K | ﹤0.01% |
30,517
-5,179
| -15% | -$177K |
|
2825
CALL
BioMarin Pharmaceuticals
BMRN
$11.6B
| $876K | ﹤0.01% |
11,600
-13,200
| -53% | -$1.08M |
|
Similar funds
Barclays's Q1 2021 Portfolio in Review
As of Q1 2021, Barclays held 5,437 positions worth $186B, down 1.6% from $189B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays withdrew a net $12.6B in Q1 2021, closing 755 positions and reducing 1,271 holdings. Its most notable exit was Stellantis, an estimated $264M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 9.6% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in Ferguson worth $253M.
- Barclays's largest Q1 2021 buy was Ferguson: 2,109,370 shares worth $253M.
- Barclays added most to Apple in Q1 2021, an estimated $1.24B increase.
- Barclays's biggest Q1 2021 reduction was iShares US Real Estate ETF, cutting an estimated $1.14B.
- Barclays fully exited Stellantis in Q1 2021, selling an estimated $264M.
- Barclays's ten largest holdings make up 37% of its $186B portfolio in Q1 2021.
- Barclays opened 555 new positions and closed 755 in Q1 2021.
- Barclays's portfolio value fell 1.6% quarter-over-quarter to $186B.
Based on Barclays's 13F filing for Q1 2021, filed 13 May 2021.